Table 1.
Baseline characteristics
| Variable |
Survivors |
Nonsurvivors |
P- value |
|---|---|---|---|
| N = 162 | N = 163 | ||
| Age, yrs: |
58.5 ± 14.6 |
63.0 ± 14.0 |
0.005 |
| Male, n(%): |
75 (46.3) |
73 (44.8) |
0.784 |
| Race, n(%): |
|
|
|
| Caucasian |
107 (66.0) |
121 (74.2) |
0.107 |
| African-American |
50 (30.9) |
41 (25.2) |
0.252 |
| Other |
5 (3.1) |
1 (0.6) |
0.121 |
| Body mass index ≥ 40, n(%): |
30.6 ± 10.9 |
29.7 ± 9.7 |
0.552 |
| Charlson comorbidity score: |
3.4 ± 3.3 |
4.4 ± 3.2 |
0.111 |
| Coexisting conditions, n(%): |
|
|
|
| Coronary artery disease |
18 (11.2) |
9 (5.5) |
0.072 |
| Chronic obstructive lung disease |
42 (26.1) |
39 (23.9) |
0.701 |
| Cirrhosis |
29 (17.9) |
37 (22.7) |
0.335 |
| Chronic kidney disease |
29 (17.9) |
22 (13.5) |
0.290 |
| Diabetes |
43 (26.5) |
39 (23.9) |
0.611 |
| Active malignancy |
21 (13.0) |
28 (17.2) |
0.353 |
| APACHE II: |
21.7 ± 6.3 |
25.1 ± 6.7 |
<0.001 |
| Mechanical ventilation, n(%): |
114 (70.4) |
140 (85.9) |
0.001 |
| Bloodstream infection, n(%): | 29 (17.9) | 34 (20.9) | 0.575 |
Values are expressed as mean ± SD. APACHE, Acute Physiology and Chronic Health Evaluation; HIV, human immunodeficiency.